SELLAS Life Sciences Group Inc (SLS) has a current stock price of $1.85. During the previous trading session, the stock witnessed a notable rise, reaching a high of $7.5 after opening at $1.84. The stock’s low for the day was $6.0, and it eventually closed at $1.7.
In terms of market performance, SELLAS Life Sciences Group Inc had a somewhat regular. The highest value for the stock in the past year was $2.27 on 07/02/25, while the lowest value was $0.77 on 12/13/24.
52-week price history of SLS Stock
Analyzing the 52-week price history of a stock, including its high and low prices, can provide valuable insight into its current status and potential future performance. SELLAS Life Sciences Group Inc’s current trading price is -18.69% away from its 52-week high, while its distance from the 52-week low is 138.99%. The stock’s price range for this period has remained between $0.77 and $2.27. The Healthcare sector company’s shares managed to surpass a trading volume of around 1.97 million for the day, which was noticeably lower compared to the shares’ average daily volume of 2.81 million over the last three months.
Financial Performance and Market Capitalization
SELLAS Life Sciences Group Inc (SLS) has experienced a quarterly decline of -4.90% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 194.28M and boasts a workforce of 15 employees.
Analysts’ Ratings For SELLAS Life Sciences Group Inc
As of right now, 2 analysts are rating SELLAS Life Sciences Group Inc as a BUY, 1 of the polled analysts branded the stock as an OVERWEIGHT, 0 analyst is recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 analyst is rating the stock as SELL.
Moving average and trading volume data
Based on Barchart.com data, the company’s moving average over the 100-day period was 1.6174, with a change in price of +0.6650. Similarly, SELLAS Life Sciences Group Inc recorded 2,485,634 in trading volume during the last 100 days, posting a change of +57.33%.
SLS Debt-to-equity ratio analysis
The debt-to-equity (D/E) ratio is a valuable metric that offers insight into a company’s financial health and standing in the market. This ratio is calculated by dividing a company’s current total liabilities by its shareholders’ equity. The D/E ratio illustrates the extent of debt a company is utilizing to support its assets in relation to the value of its shareholders’ equity. At the time of writing, the total D/E ratio for SLS stands at 0.03. Similarly, the long-term debt-to-equity ratio is also 0.01.
SLS Stock Stochastic Average
As of today, the raw stochastic average of SELLAS Life Sciences Group Inc over the past 50 days is 44.42%. This is a decrease compared to the raw stochastic average of the last 20 days, which was recorded at 85.53%. Additionally, the Stochastic %K and %D values for the company were 59.67% and 43.32%, respectively, over the past 20 days.
SLS Stock Price Performance Analysis
A mixed performance in the stock price over the year has left investors with either an optimistic or pessimistic outlook, depending on their point of view. The index has shown a price gain of 39.77% this year. Over the last six months, there has been a weaker performance of 46.43%. The price of SLS fallen by 0.27% during the last 30 days period. For the last 5-days stocks have improved 19.03%.
